Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice

Hafid Ait-Oufella1, Cédric Collin, Erwan Bozec

  • 1Department of Pharmacology, European Hospital Georges Pompidou, France.

Insights

Long-term antihypertensive treatment significantly reduces aortic stiffness in patients with essential hypertension. This improvement in arterial stiffness is linked to arterial remodeling, not just blood pressure reduction.

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research
  • Vascular Biology

Background:

  • The long-term impact of antihypertensive treatment on aortic stiffness, independent of blood pressure reduction, remains unclear.
  • Previous studies have not definitively demonstrated a sustained decrease in aortic stiffness after several years of treatment.

Purpose of the Study:

  • To investigate whether antihypertensive treatment can lead to a blood pressure-independent reduction in aortic stiffness over several years.
  • To assess the association between changes in aortic stiffness and blood pressure parameters in treated hypertensive patients.

Main Methods:

  • Observational study including 97 patients with treated essential hypertension.
  • Measurements of aortic stiffness (carotid-femoral pulse wave velocity) and pulse pressure (applanation tonometry) over a mean follow-up of 5.3 years.
  • Analysis using linear mixed models and multivariate analysis to determine associations between aortic stiffness and blood pressure changes.

Main Results:

  • Significant reduction in aortic stiffness (PWV) and central systolic blood pressure (SBP) and pulse pressure (PP) over the follow-up period.
  • Aortic stiffness reduction was only slightly explained by blood pressure reduction, suggesting a blood pressure-independent effect.
  • Decrease in central pulse pressure was largely explained by the reduction in aortic stiffness.

Conclusions:

  • Long-term antihypertensive treatment can achieve a substantial and sustained decrease in aortic stiffness in routine clinical practice.
  • These improvements in aortic stiffness are likely due to arterial remodeling, a delayed response to normalized blood pressure and cardiovascular risk factors.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...